| Sep 3 |
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024
|
| Aug 6 |
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot
|
| Aug 6 |
Anavex Life Sciences GAAP EPS of -$0.14 beats by $0.02
|
| Aug 6 |
Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update
|
| Aug 1 |
Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024
|
| Jul 30 |
Anavex: An Update To Their Phase 2b/3 Alzheimer's Trial Data
|
| Jul 30 |
Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference
|
| Jul 29 |
Anavex Life Sciences files to sell $150M of common stock
|
| Jul 29 |
Anavex Life Sciences: Short-Lived Spike On Latest Alzheimer's Data Not Surprising
|
| Jul 29 |
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
